ENZALUTAMIDFORMULIERUNGEN

European patent · EP4450130 · In force

Register entry

Publication number
EP4450130
Application number
EP24198653
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 11, 2013
Published
Oct 23, 2024
Granted
Jul 15, 2026
Protection ends at the latest
Sep 10, 2033
Next annual fee due
Sep 30, 2027
IPC classes
C07D 233/86 (2006.01)
A61K 31/4166 (2006.01)
A61P 35/00 (2006.01)
A61K 9/14 (2006.01)
A61K 9/20 (2006.01)
A61K 9/16 (2006.01)
A61P 13/08 (2006.01)
A61P 15/00 (2006.01)
A61P 15/08 (2006.01)
A61P 15/14 (2006.01)
A61P 43/00 (2006.01)
Priority
US 201261699351 P 11.09.2012
Divided from
EP23205739
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Sep 16, 2026

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 16.09.2026

  3. Jul 15, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 15.07.2026

Parties

Inventor

Lorenz, Douglas Alan

Bend, 97701, US

Konagurthu, Sanjay

Bend, 97701, US

Wald, Randy J.

Bend, 97701, US

Everett, Jason A.

Bend, 97701, US

Matz, Sheila

New York, 10017, US

Takaishi, Yuuki

Tokyo, 103-8411, JP

Sakai, Toshiro

Tokyo, 103-8411, JP

Irie, Ryousuke

Tokyo, 103-8411, JP

Oba, Shinsuke

Tokyo, 103-8411, JP

Toyota, Hiroyasu

Tokyo, 103-8411, JP

Nishimura, Koji

Tokyo, 103-8411, JP

Kanbayashi, Atsushi

Tokyo, 103-8411, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.